Alhamadani, Isra, Mohammed Alzyadi, and Mohauman Majeed. 2026. “Prognostic Significance of the CXCL11/CXCL9/CD163 Immune Signature in Triple-Negative Breast Cancer: A Bioinformatics and Survival Analysis: CXCL11/CXCL9 Prognostic Value”. Archives of Breast Cancer 13 (2):154-65. https://doi.org/10.32768/abc.6274819305-647.